NTLA
Intellia Therapeutics Inc
12.40$
-3.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.14 | -0.02 | 0.30 | 0.07 | 0.09 | 0.13 | 0.16 | 0.14 | 0.13 | 0.21 | 0.13 | 0.06 | 0.45 | |
| 0.03 | 0.03 | 0.03 | 0.03 | 1.08 | 1.15 | – | 0.78 | 0.72 | 0.06 | 0.02 | – | – | |
| 0.11 | -0.05 | 0.28 | 0.04 | -0.99 | -1.02 | 0.16 | -0.64 | -0.59 | 0.16 | 0.11 | 0.06 | -0.21 | |
| 1.28 | 1.20 | 1.14 | 1.15 | 1.22 | 1.15 | 1.05 | 0.94 | 0.86 | 0.82 | 0.68 | 0.62 | 2.60 | |
| 0.33 | 0.32 | 0.33 | 0.33 | 0.30 | 0.32 | 0.28 | 0.26 | 0.28 | 0.31 | 0.29 | 0.28 | 1.02 | |
| 1.59 | 1.50 | 1.47 | 1.48 | 0.44 | 0.32 | 1.33 | 0.42 | 0.42 | 1.07 | 0.96 | 0.90 | 2.97 | |
| -1.48 | -1.55 | -1.19 | -1.43 | -1.43 | -1.34 | -1.17 | -1.06 | -1.01 | -0.91 | -0.85 | -0.84 | -3.17 | |
| – | 0.10 | – | – | – | – | – | – | – | – | – | – | – | |
| -1.38 | -1.46 | -1.12 | -1.52 | -1.34 | -1.27 | -1.10 | -0.98 | -0.92 | -0.88 | -0.81 | -0.80 | -3.00 | |
| -0.17 | 0.45 | 0.03 | – | – | – | – | – | – | – | – | – | – | |
| -1.38 | -1.46 | -1.12 | -1.52 | -1.34 | -1.27 | -1.10 | -0.98 | -0.92 | -0.88 | -0.81 | -0.80 | -3.00 | |
| -1.35 | -1.43 | -1.10 | -1.49 | -1.32 | -1.24 | -1.08 | -0.95 | -0.87 | -0.88 | -0.79 | -0.78 | -2.92 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.